three-year outcom mainten therapi recurr depress random mainten trial patient recurr depress short-term continu treatment imipramin hydrochlorid interperson psychotherapi five-cel design mainten form interperson psychotherapi combin medic signific role prevent recurr second question antidepress medic dosag acut episod mainten dosag prophylaxi superior trial mainten dosag strategi surviv analysi signific prophylact effect activ imipramin hydrochlorid averag dose mg modest prophylact effect monthli interperson psychotherapi activ imipramin hydrochlorid averag dose mg effect mean recurr monthli interperson psychotherapi serv time episod patient activ medic 